Treatment and outcome of hepatorenal syndrome in Japan: a retrospective cohort study using a national inpatient database

[1]  H. Yoshiji,et al.  Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 , 2021, Journal of Gastroenterology.

[2]  H. Yoshiji,et al.  Evidence‐based clinical practice guidelines for liver cirrhosis 2020 , 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  P. Angeli,et al.  News in Pathophysiology, Definition and Classification of Hepatorenal Syndrome: a step beyond the International Club of Ascites (ICA) Consensus document. , 2019, Journal of hepatology.

[4]  R. Moreau,et al.  Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. , 2019, Gastroenterology.

[5]  S. Sarin,et al.  Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure , 2019, Hepatology.

[6]  J. Trebicka,et al.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.

[7]  S. Uemoto,et al.  Influence of hepatorenal syndrome on outcome of living donor liver transplantation: A single‐center experience in 357 patients , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  M. Murad,et al.  Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. , 2017, The lancet. Gastroenterology & hepatology.

[9]  H. Horiguchi,et al.  Validity of diagnoses, procedures, and laboratory data in Japanese administrative data , 2017, Journal of epidemiology.

[10]  H. Yasunaga,et al.  In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan , 2016, Critical Care.

[11]  Ezio Fornasiere,et al.  Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial , 2015, Hepatology.

[12]  N. Ohuchi,et al.  Renal function status in liver transplant patients in the first month post‐transplant is associated with progressive chronic kidney disease , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  M. Poca,et al.  Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. , 2014, Journal of hepatology.

[14]  K. Shiraki,et al.  Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors. , 2014, Transplantation proceedings.

[15]  A. Craxì,et al.  Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. , 2013, World journal of hepatology.

[16]  Virendra Singh,et al.  Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study. , 2012, Journal of hepatology.

[17]  A. Sanyal,et al.  Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1 * , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  John P. Rice,et al.  Liver Transplant Outcomes for Patients With Hepatorenal Syndrome Treated With Pretransplant Vasoconstrictors and Albumin , 2011, Transplantation.

[19]  Kinshuk Jerath,et al.  The Impact of "One-Stop Shopping" on Competitive Store Brand Strategy , 2009 .

[20]  M. Rizzetto,et al.  Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. , 2007, Journal of hepatology.

[21]  Vicente Arroyo,et al.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.

[22]  W. Jiménez,et al.  A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis , 2005, Hepatology.

[23]  F. Roudot-thoraval,et al.  Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study , 2002, Hepatology.

[24]  F. Durand,et al.  Hepatorenal syndrome , 1996, Digestive Diseases and Sciences.

[25]  J. Schölmerich,et al.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.

[26]  W. Jiménez,et al.  Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. , 1993, Gastroenterology.

[27]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[28]  Hideo Yasunaga,et al.  Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database , 2019, Annals of Clinical Epidemiology.

[29]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..